Registry of Lobbyists
Subject matters | Details | Categories |
---|---|---|
Economic Development,
International Trade
|
ACCESS & BENEFIT SHARING: TRIPS AGREEMENT in respect of protecting intellectual property and preventing increased uncertainty
|
Policies or Program
|
Agriculture
|
ADVENTITIOUS PRESCENCE POLICY in respect of new agricultural biotechnology products
|
Policies or Program
|
Environment
|
BIOSAFETY PROTOCOL in respect of Canada's participation in global discussions to ensure an enabling environment for safe new technologies
|
Policies or Program
|
Environment,
Health,
Industry
|
CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS in respect of modern, science-based regulations to reflect rapidly changing new technologies
|
Legislative Proposal, Bill or Resolution,
Regulation
|
Taxation and Finance
|
Clarify the administration of SR&ED program to ensure clinical trials and international research conducted in Canada qualifies as eligible expenses
|
Policies or Program
|
Intellectual Property
|
Creation of a modern policy environment that recognizes international standards and reviews, and establishes clarity on data ownership for intellectual property
|
Policies or Program
|
Health,
Industry
|
Establish accountability with the federally established Canadian Drug Agency (formerly Canadian Agency for Drugs and Technologies and Health) (CADTH) and its Common Drug Review process (Health Canada)
|
Policies or Program
|
Agriculture,
Health,
Industry,
International Trade
|
FOOD AND DRUGS ACT AND REGULATIONS in respect of streamlining regulatory burden and ensuring appropriate climate for the introduction of new technologies
|
Legislative Proposal, Bill or Resolution,
Regulation
|
Agriculture,
Consumer Issues,
Health,
Industry
|
FOOD LABELLING in respect of mitigating the unnecessary introduction of new labelling requirements for products already approved under current regulated process and in respect of maintaining harmonization of requirements with trading nations
|
Policies or Program
|
Budget,
Economic Development,
Industry,
Research and Development,
Taxation and Finance
|
IMPROVEMENTS TO THE Scientifc Research & Experimental Development TAX CREDITS
|
Policies or Program
|
Intellectual Property,
International Trade
|
INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS in respect of creating Canada as one of the world's most competitive jurisdictions in protecting IP (e.g., match level of European Union via CETA negotiations)
|
Policies or Program,
Regulation
|
Agriculture,
Health,
Industry
|
NOVEL FOODS in respect of maintaining a science-based regulatory system for novel foods derived from plant and animal biotechnology
|
Policies or Program
|
Economic Development,
Health,
Industry,
Research and Development
|
ORPHAN PRODUCTS to establish formal regulations, policies or programs to encourage the research, development and introduction of new technologies to treat "orphan" or neglected diseases
|
Policies or Program,
Regulation
|
Health,
Industry,
Internal Trade,
Research and Development
|
PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW to ensure new guidelines and directives do not create disincentives for the introduction of new treatments in Canada
|
Policies or Program
|
Agriculture,
Health,
Industry,
International Trade
|
REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS as NOVEL FOODS or INDUSTRIAL BIO_PRODUCTS in respect of an efficient science-based approach and allows for greater cooperation among and between government departments
|
Policies or Program,
Regulation
|
Agriculture,
Budget,
Economic Development,
Environment,
Health,
Industry,
Research and Development,
Science and Technology
|
RESEARCH & DEVELOPMENT (R&D) to ensure Canadian capacity in key sectors including biomanufacturing, life sciences, and biotechnology.
|
Policies or Program
|
Health
|
SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW to ensure Canada remains competitive overall and any new costs do not put bioloigics are a comparative disadvantage
|
Policies or Program
|
Health,
Industry,
International Trade,
Research and Development
|
VACCINE CONTRACTING AND SUPPLY to support the implementation of the federal biomanufacturing strategy, regulation of vaccines for Canadians, address immunization gaps, provide updated and timely information about vaccine development pipeline, support procurement of vaccines
|
Policies or Program
|
Health,
Industry,
International Trade,
Research and Development
|
Vaccine Funding - National Immunization Strategy - maintain federal leadership in providing provinces with funding for new vaccines
|
Policies or Program
|
Subject matters | Details | Categories |
---|---|---|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
ACCESS & BENEFIT SHARING: TRIPS AGREEMENT in respect of protecting intellectual property and preventing increased uncertainty
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
ADVENTITIOUS PRESCENCE POLICY in respect of new agricultural biotechnology products
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
BIOSAFETY PROTOCOL in respect of Canada's participation in global discussions to ensure an enabling environment for safe new technologies
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
CANADIAN ENVIRONMENTAL PROTECTION ACT AND REGULATIONS in respect of modern, science-based regulations to reflect rapidly changing new technologies
|
Legislative Proposal, Bill or Resolution,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Clarify the administration of SR&ED program to ensure clinical trials and international research conducted in Canada qualifies as eligible expenses
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Creation of a modern policy environment that recognizes international standards and reviews, and establishes clarity on data ownership for intellectual property
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Establish accountability with the federally financed Canadian Agency for Drugs and Technologies and Health (CADTH) and its Common Drug Review process (Health Canada)
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
FOOD AND DRUGS ACT AND REGULATIONS in respect of minimizing regulatory burden and ensuring appropriate climate for the introduction of new technologies
|
Legislative Proposal, Bill or Resolution,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
FOOD LABELLING in respect of mitigating the unnecessary introduction of new labelling requirements for products already approved under current regulated process and in respect of maintaining harmonization of requirements with trading nations
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
IMPROVED TAXATION & INVESTMENT FRAMEWORK in respect of extending Canada's flow-through shares program to biotechnology companies for increased domestic investments.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
IMPROVEMENTS TO THE Scientifc Research & Experimental Development TAX CREDITS in respect of updating the 20 yr old system by removing the punitive Canadian Controlled Private Companies restriction and increasing the expenditure limit for refundable credits
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
INTELLECTUAL PROPERTY/PATENT POLICY AND REGULATIONS in respect of creating Canada as one of the world's most competitive jurisdictions in protecting IP (e.g., match level of European Union via CETA negotiations)
|
Policies or Program,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
NOVEL FOODS in respect of maintaining a science-based regulatory system for novel foods derived from plant and animal biotechnology
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
ORPHAN PRODUCTS to establish formal regulations, policies or programs to encourage the research, development and introduction of new technologies to treat "orphan" or neglected diseases
|
Policies or Program,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
PATENTED MEDECINES PRICES REVIEW BOARD (PMPRB) PRICE REVIEW to ensure new guidelines and directives do not create disincentives for the introduction of new treatments in Canada
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
REGULATORY APPROVAL PROCESS FOR PLANTS WITH NOVEL TRAITS as NOVEL FOODS or INDUSTRIAL BIO_PRODUCTS in respect of an efficient science-based approach and allows for greater cooperation among and between government departments
|
Policies or Program,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
RESEARCH & DEVELOPMENT (R&D) in respect on providing input to the government's expert panel on business R&D to improve incentives for research in Canada
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Regulatory framework for subsequent entry biologics to ensure an appropriate and transparent appraoch for the safe introduction of biosimilars
|
Policies or Program,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
SCIENCE & TECHNOLOGY STRATEGY in respect of encouraging a strong government focus to stimulate the development, use and retention of biotechnology products, processes and companies
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
SUBMISSION REVIEW PROCESS FOR BIOLOGICS, COST RECOVERY REVIEW to ensure Canada remains competitive overall and any new costs do not put bioloigics are a comparative disadvantage
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
SUBSEQUENT ENTRY BIOLOGICS to establish formal regulations to prescribe the requirements for introduction of biosimilars and ensure the protection of intellectual property for first entry biologics
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Vaccine Funding - National Immunization Strategy - to re-establish federal leadership in providing provinces with funding for new vaccines under a renewed national immunization strategy framework
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Vaccine contracting and supply
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
WORLD TRADE ORGANIZATION (WTO) in respect of Canada's contribution and participation to encourage a sound business climate and to faciliate Canada's access to European markets for genetically engineered agricultural and animal products
|
Policies or Program
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Date | DPOH, Position Title | Government Institution | Subject Matters |
---|---|---|
2024-07-18 |
|
Taxation and Finance |
2024-07-04 |
|
Health, Industry, Research and Development, Taxation and Finance |
2024-07-04 |
|
Health, Industry, Research and Development |
2024-07-03 |
|
Health, Industry, Research and Development |
2024-06-13 |
|
Economic Development, Industry |
2024-06-11 |
|
Economic Development, Industry, Taxation and Finance |
2024-05-30 |
|
Economic Development, Taxation and Finance |
2024-05-28 |
|
Economic Development, Health, Industry |
2024-05-13 |
|
Economic Development, Industry, Taxation and Finance |
2024-05-01 |
|
Budget, Economic Development, Industry, Taxation and Finance |
2024-04-18 |
|
Health, Industry, Research and Development |
2024-03-26 |
|
Industry, Budget, Economic Development |
2024-01-23 |
|
Industry |
2024-01-18 |
|
Industry |
2024-01-04 |
|
Industry |
2023-12-14 |
|
Health, Industry |
2023-12-14 |
|
Health, Industry |
2023-12-05 |
|
Health, Industry |
2023-11-03 |
|
Industry, Economic Development |
2023-11-01 |
|
Industry |
2023-10-26 |
|
Industry, Economic Development |
2023-10-25 |
|
Industry, Economic Development |
2023-10-24 |
|
Health, Industry |
2023-10-17 |
|
Health, Industry |